NTRK1 and neoplasm: Cha [126] looks at the expression of the receptor tyrosine kinase ephrin receptor A10 (EphA10), which is undetectable in most normal tissues and at the correlation with tumor progression and poor prognosis in a number of malignancies, including triple-negative breast cancer (TNBC).